FOLD Dividend: Amicus Therapeutics Inc Yield Insights

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	598	528	399	329	305	260
Revenue Growth (YoY)	21%	32%	21%	8%	17%	43%
Cost of Revenue	61	52	37	38	34	31
Gross Profit	537	475	362	290	271	229
Selling, General & Admin	353	323	275	213	192	156
Research & Development	142	109	152	276	272	308
Operating Expenses	502	441	438	496	477	476
Other Non Operating Income (Expenses)	14	-9	-15	4	-2	0
Pretax Income	4	-28	-150	-242	-241	-274
Income Tax Expense	19	27	1	-5	8	2
Net Income	-14	-56	-151	-236	-250	-276
Net Income Growth	-87%	-63%	-36%	-6%	-9%	-22%
Shares Outstanding (Diluted)	310.43	304.38	295.16	289.1	271.4	258.9
Shares Change (YoY)	2%	3%	2%	7%	5%	8%
EPS (Diluted)	-0.04	-0.18	-0.51	-0.82	-0.92	-1.07
EPS Growth	-87%	-64%	-37%	-11%	-14%	-28%
Free Cash Flow	9	-37	-76	-170	-206	-236
Free Cash Flow Per Share	0.02	-0.12	-0.25	-0.58	-0.75	-0.91
Gross Margin	89.79%	89.96%	90.72%	88.14%	88.85%	88.07%
Operating Margin	5.68%	6.43%	-19.04%	-62.31%	-67.54%	-95%
Profit Margin	-2.34%	-10.6%	-37.84%	-71.73%	-81.96%	-106.15%
Free Cash Flow Margin	1.5%	-7%	-19.04%	-51.67%	-67.54%	-90.76%
EBITDA	41	42	-69	-200	-200	-239
EBITDA Margin	6.85%	7.95%	-17.29%	-60.79%	-65.57%	-91.92%
D&A For EBITDA	7	8	7	5	6	8
EBIT	34	34	-76	-205	-206	-247
EBIT Margin	5.68%	6.43%	-19.04%	-62.31%	-67.54%	-95%
Effective Tax Rate	475%	-96.42%	-0.66%	2.06%	-3.31%	-0.72%

Amicus Therapeutics Inc (FOLD) Price